Cargando…

Utility of the Enzyme-Linked Immunospot Interferon-γ–Release Assay to Predict the Risk of Cytomegalovirus Infection in Hematopoietic Cell Transplant Recipients

The ability to distinguish allogeneic hematopoietic cell transplant (allo-HCT) recipients at risk for cytomegalovirus (CMV) reactivation from those who are not is central for optimal CMV management strategies. Interferon γ (IFN-γ) produced by CMV-challenged T cells may serve as an immune marker diff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nesher, Lior, Shah, Dimpy P., Ariza-Heredia, Ella J., Azzi, Jacques M., Siddiqui, Hala K., Ghantoji, Shasank S., Marsh, Lisa Y., Michailidis, Lamprinos, Makedonas, George, Rezvani, Katy, Shpall, Elizabeth J., Chemaly, Roy F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2016
Materias:	Major Articles and Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857477/ https://www.ncbi.nlm.nih.gov/pubmed/26908740 http://dx.doi.org/10.1093/infdis/jiw064

Ejemplares similares

1120 The Impact of Influenza Vaccination in Patients with Cancer on Subsequent Disease during the 2013-2014 Influenza Season
por: Azzi, Jacques, et al.
Publicado: (2014)

Use of Oral Ribavirin for the Treatment of RSV Infections in Hematopoietic Cell Transplant (HCT) Recipients
por: Foolad, Farnaz, et al.
Publicado: (2017)

1583. The Utility of the Immunodeficiency Scoring Index (ISI) to Predict Outcomes of Coronavirus (HCoV) Infections in Hematopietic Cell Transplant (HCT) Recipients
por: Khawaja, Fareed, et al.
Publicado: (2018)

Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant
por: Ariza-Heredia, Ella J, et al.
Publicado: (2023)

1995. Duration of letermovir primary prophylaxis in hematopoietic cell transplant recipients at high risk for cytomegalovirus infections and impact on outcomes
por: Febres-Aldana, Anthony J, et al.
Publicado: (2023)

Nosocomial COVID-19 at a comprehensive cancer center during the first year of the pandemic: Lessons learned
por: Khawaja, Fareed, et al.
Publicado: (2023)

Real-World Outcomes Associated With Letermovir Use for Cytomegalovirus Primary Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients: A Systematic Review and Meta-analysis of Observational Studies
por: Vyas, Ami, et al.
Publicado: (2022)

2119. Predictive Value of the Immunodeficiency Scoring Index for COVID-19 Related Outcomes in Hematopoietic Transplant Recipients
por: Daher, Marilyne, et al.
Publicado: (2022)

568. Healthcare Cost and Length of Stay for Cytomegalovirus (CMV) Infection-Related Hospitalizations in Allogeneic Hematopoietic Cell Transplant (allo-HCT) recipients: A Multicenter Analysis
por: Khawaja, Fareed, et al.
Publicado: (2020)

1538. High Mortality of Cytomegalovirus (CMV) Pneumonia in Hematopietic Cell Transplant Recipients
por: Batista, Marjorie, et al.
Publicado: (2018)

Outcomes of Cytomegalovirus Viremia Treatment in Critically Ill Patients With COVID-19 Infection
por: Schoninger, Scott, et al.
Publicado: (2022)

Risk factors for mortality after respiratory syncytial virus lower respiratory tract infection in adults with hematologic malignancies
por: Vakil, Erik, et al.
Publicado: (2018)

Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes
por: El Chaer, Firas, et al.
Publicado: (2017)

Diagnosis of Tuberculosis by an Enzyme-Linked Immunospot Assay for Interferon-γ
por: Wang, Jann-Yuan, et al.
Publicado: (2007)

2122. The Impact of HHV-6 DNAemia on hematopoietic cell transplant (HCT) recipients at high risk for CMV reactivation in the era of Letermovir
por: Srinivasan, Krithia, et al.
Publicado: (2022)

Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial( )
por: Avery, Robin K, et al.
Publicado: (2021)

Accelerated T-Cell Immunosenescence in Cytomegalovirus-Seropositive Individuals After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
por: Álvarez-Heredia, Pablo, et al.
Publicado: (2023)

Enumeration and Characterization of Human Memory T Cells by Enzyme-Linked Immunospot Assays
por: Calarota, Sandra A., et al.
Publicado: (2013)

Acute and latent viral infections in immunocompromised patients: a tale of brave battles and menacing foes
por: Spallone, Amy, et al.
Publicado: (2022)

Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation
por: Lodding, I P, et al.
Publicado: (2018)

Association of Cytomegalovirus DNA and Immunologic Markers of Cardiovascular Disease
por: Garg, Ankita, et al.
Publicado: (2019)

A Prospective Study of Cytomegalovirus-Specific Cell-Mediated Immune Monitoring and Cytomegalovirus Infection in Patients With Active Systemic Lupus Erythematosus Receiving Immunosuppressants
por: Bruminhent, Jackrapong, et al.
Publicado: (2021)

Interferon-γ Enzyme-Linked Immunospot Assay in Patients with Tuberculosis and Healthy Adults
por: Kim, Cheol-Hong, et al.
Publicado: (2014)

Our experience with enzyme-linked immunospot assay in the laboratory diagnostics of lyme borreliosis
por: Ondrejkova, Andrea, et al.
Publicado: (2015)

Immune monitoring technology primer: the enzyme-linked immunospot (Elispot) and Fluorospot assay
por: Janetzki, Sylvia
Publicado: (2015)

In Utero Activation of Natural Killer Cells in Congenital Cytomegalovirus Infection
por: Vaaben, Anna V, et al.
Publicado: (2022)

Another tool against cytomegalovirus after allogeneic hematopoietic cell transplantation
por: Chen, George L., et al.
Publicado: (2023)

Respiratory Viral Infections in Recipients of Cellular Therapies: A Review of Incidence, Outcomes, Treatment, and Prevention
por: Wilson Dib, Rita, et al.
Publicado: (2023)

The Excess Burden of Cytomegalovirus in African American Communities: A Geospatial Analysis
por: Lantos, Paul M., et al.
Publicado: (2015)

Emergence and Persistence of Letermovir-Resistant Cytomegalovirus in a Patient With Primary Immunodeficiency
por: Popping, Stephanie, et al.
Publicado: (2019)

Enumeration of Functional T-Cell Subsets by Fluorescence-Immunospot Defines Signatures of Pathogen Burden in Tuberculosis
por: Casey, Rosalyn, et al.
Publicado: (2010)

A Case of Sulfasalazine-Induced Hypersensitivity Syndrome Confirmed by Enzyme-Linked Immunospot Assay
por: Phatharacharukul, Parkpoom, et al.
Publicado: (2013)

Human Cytomegalovirus Up-Regulates Endothelin Receptor Type B: Implication for Vasculopathies?
por: Yaiw, Koon-Chu, et al.
Publicado: (2015)

Molecular and Culture-Based Bronchoalveolar Lavage Fluid Testing for the Diagnosis of Cytomegalovirus Pneumonitis
por: Tan, Susanna K., et al.
Publicado: (2016)

Cardiac Microvascular Dysfunction in Women Living With HIV Is Associated With Cytomegalovirus Immunoglobulin G
por: Knudsen, Andreas, et al.
Publicado: (2018)

Cytomegalovirus Latent Infection is Associated with an Increased Risk of COVID-19-Related Hospitalization
por: Alanio, Cécile, et al.
Publicado: (2022)

Cytomegalovirus Viremia Predicts Postdischarge Mortality in Kenyan HIV-Exposed Uninfected Children( )
por: Pavlinac, Patricia B, et al.
Publicado: (2022)

Comparison of Standardized Cytomegalovirus (CMV) Viral Load Thresholds in Whole Blood and Plasma of Solid Organ and Hematopoietic Stem Cell Transplant Recipients with CMV Infection and Disease
por: Dioverti, M Veronica, et al.
Publicado: (2017)

The efficacy of endoscopic therapy for pancreas divisum: a meta-analysis
por: Michailidis, Lamprinos, et al.
Publicado: (2017)

Cytomegalovirus Retinitis Screening and Treatment in Human Immunodeficiency Virus Patients in Malawi: A Feasibility Study
por: Ocieczek, Paulina, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kajonc8jq3gafe2p54l0urlq8t